Can-Fite BioPharma Ltd.
CANF- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001536196
No open-market purchases or sales by Can-Fite BioPharma Ltd. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $149.1K in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Can-Fite BioPharma Ltd. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Q1 2026 | Change |
|---|---|---|---|
| Holders | 16 | 14 | −2 |
| SharesConverted for a 1-for-20 split | 29.8K | 138.3K | +108.5K (+363.6%) |
| Value | $78.3K | $428.6K | +$350.3K (+447.4%) |
New holders (5)
Institutions that held Can-Fite BioPharma Ltd. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sabby Management, LLC | 42,559 | $131.9K | 2.31% |
| Citadel Advisors LLC | 34,150 | $105.9K | 0.00% |
| HRT Financial LP | 19,383 | $60.0K | 0.00% |
| Virtu Financial LLC | 12,908 | $40.0K | 0.00% |
| Citigroup Inc | 5,482 | $17.0K | 0.00% |
Sold out (7)
Institutions that held Can-Fite BioPharma Ltd. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| XTX Topco Ltd | 18,686 | $3.74K |
| Bogart Wealth, LLC | 15,045 | $3.01K |
| Two Sigma Securities, LLC | 12,088 | $2.42K |
| Costello Asset Management, INC | 1,000 | $200 |
| EverSource Wealth Advisors, LLC | 68 | $14 |
| SBI Securities Co., Ltd. | 1 | $0 |
| Jane Street Group, LLC | 205,004 | – |